Pivotal Therapeutics Inc.
OTC: PVTTF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Rachelle MacSweeney
- Headquarters
- Woodbridge, Canada
- IPO year
- 2012
- Market cap
- $172.4K
- Website
- https://www.pivotaltherapeutics.us
Loading PVTTF…
Loading profile data…Frequently asked questions about PVTTF
What does Pivotal Therapeutics Inc. (PVTTF) do?
Pivotal Therapeutics Inc. is a specialized pharmaceutical firm primarily dedicated to addressing cardiovascular ailments and promoting general well-being. The company's flagship offering, VASCAZEN, is a medical food available by prescription only. It's specifically designed for the clinical dietary intervention of cardiovascular disease in indiv...
Where does PVTTF trade?
Pivotal Therapeutics Inc. (PVTTF) trades on the Other OTC.
What sector is PVTTF in?
Pivotal Therapeutics Inc. (PVTTF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Pivotal Therapeutics Inc.?
Rachelle MacSweeney is the chief executive officer of Pivotal Therapeutics Inc. (PVTTF).
Where is Pivotal Therapeutics Inc. headquartered?
Pivotal Therapeutics Inc. is headquartered in Canada.
Does PVTTF pay a dividend?
Pivotal Therapeutics Inc. (PVTTF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PVTTF go public?
Pivotal Therapeutics Inc. (PVTTF) completed its initial public offering in 2012.